[1] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy [J]. N Engl J Med, 2008, 358(7): 2649-2651. [2] Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas [J]. Eur J Pediatr, 2011, 170(4): 493-501. [3] Waner M, O TM. The role of surgery in the management of congenital vascular anomalies [J]. Tech Vasc Interv Radiol, 2013, 16(1): 45-50. [4] 王绪凯. 脉管性疾病的治疗 [J]. 中国实用口腔科杂志, 2009, 2(5): 280-282. [5] Buckmiller LM, Munson PD, Dyamenahalli U, et al, Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center [J]. Laryngoscope, 2010, 120(4): 676-681. [6] Naouri M, Schill T, Maruani A, et al. Successful treatment of ulcerated haemangioma with propranolol [J]. J Eur Acad Dermatol Venereol, 2010, 24(9): 1109-1112. [7] Arneja JS, Mulliken JB. Resection of amblyogenic periocular hemangiomas: indications and outcomes [J]. Plast Reconstr Surg, 2010, 125(1):274-281. [8] Alomari AI, Karian VE, Lord DJ, et al. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement[J]. J Vasc Interv Radiol, 2006, 17(10):1639-1648. [9] Xue L, Qin XJ, Wang XK, et al. Effect of electrochemical treatment on high-flow vascular malformations in the maxillofacial region [J]. Br J Oral Maxillofac Surg, 2011, 49(8): 630-634. [10] 魏景健, 李沁江, 王绪凯, 等. 电化学疗法联合平阳霉素治疗高回流量静脉畸形的临床疗效分析 [J]. 中华口腔医学杂志, 2012, 47(3): 160-163. [11] 成爱武, 马平生. 环扎电凝术治疗血管瘤和脉管畸形 [J]. 中国药物经济学, 2012, 1(1): 72-73. |